Federal State Budgetary Institution "Research Centre For Medical Genetics", Moscow, 115478, Russia.
Sci Rep. 2019 Oct 8;9(1):14412. doi: 10.1038/s41598-019-50911-9.
Hereditary spastic paraplegia (HSP) comprises a heterogeneous group of neurodegenerative disorders, it share common symptom - of progressive lower spastic paraparesis. The most common autosomal dominant (AD) forms of HSP are SPG4 (SPAST gene) and SPG3 (ATL1 gene). In the current research we investigated for the first time the distribution of pathogenic mutations in SPAST and ATL1 genes within a large cohort of Russian HSP patients (122 probands; 69 famillial cases). We determined the frequencies of genetic abnormalities using Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA), and Next Generation Sequencing (NGS) of targeted gene panels. As a result, SPG4 was diagnosed in 30.3% (37/122) of HSP cases, where the familial cases represented 37.7% (26/69) of SPG4. In total 31 pathogenic and likely pathogenic variants were detected in SPAST, with 14 new mutations. Among all detected SPAST variants, 29% were gross deletions and duplications. The proportion of SPG3 variants in Russian cohort was 8.2% (10/122) that were all familial cases. All 10 detected ATL1 mutations were missense substitutions, most of which were in the mutational hot spots of 4, 7, 8, 12 exons, with 2 novel mutations. This work will be helpful for the populational genetics of HSP understanding.
遗传性痉挛性截瘫(HSP)是一组异质性的神经退行性疾病,其共同的特征是进行性下肢痉挛性截瘫。最常见的常染色体显性(AD)形式的 HSP 是 SPG4(SPAST 基因)和 SPG3(ATL1 基因)。在目前的研究中,我们首次调查了 SPAST 和 ATL1 基因中的致病突变在俄罗斯 HSP 患者(122 名先证者;69 名家族病例)中的分布。我们使用 Sanger 测序、多重连接依赖性探针扩增(MLPA)和靶向基因panel 的下一代测序(NGS)来确定遗传异常的频率。结果,SPG4 在 30.3%(37/122)的 HSP 病例中被诊断出来,其中家族病例占 SPG4 的 37.7%(26/69)。在 SPAST 中总共检测到 31 个致病性和可能致病性的变体,其中包括 14 个新的突变。在所有检测到的 SPAST 变体中,29%是大片段缺失和重复。俄罗斯队列中 SPG3 变体的比例为 8.2%(10/122),均为家族病例。所有检测到的 10 个 ATL1 突变均为错义替换,其中大多数位于 4、7、8、12 号外显子的突变热点,其中有 2 个新突变。这项工作将有助于理解 HSP 的群体遗传学。